Evidence map›Paper›PMID 35971066›Full record

ArticleBMC infectious diseases2022

Screening and assessment for post-acute COVID-19 syndrome (PACS), guidance by personal pilots and support with individual digital trainings within intersectoral care: a study protocol of a randomized controlled trial.

Alina Dahmen, Franziska M Keller, Christina Derksen, Robin Rinn, Petra Becker, Sonia Lippke

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMC infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05238415 (ASAP - Assisted Immediate Augmented Post-/Long-COVID Plan), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05238415 nacompletednot on this map

ASAP - Assisted Immediate Augmented Post-/Long-COVID Plan

TypeinterventionalSponsorProf. Dr. Sonia LippkeRan2021 to 2023Enrolled192ConditionsLong-COVID, Post-COVID, Psychosomatic Disorder, Psychological DistressArmsPsychological and Physiological Assessments
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Alina DahmenKlinikum Wolfsburg, Sauerbruchstraße 7, 38440, Wolfsburg, Germany.ORCID 0000-0001-8591-874X
Franziska M KellerJacobs University Bremen gGmbH, Campus Ring 1, 28759, Bremen, Germany.ORCID 0000-0002-7728-9709
Christina DerksenJacobs University Bremen gGmbH, Campus Ring 1, 28759, Bremen, Germany.ORCID 0000-0002-4663-1882
Robin RinnJacobs University Bremen gGmbH, Campus Ring 1, 28759, Bremen, Germany.ORCID 0000-0002-2640-8325
Petra BeckerDr. Becker Klinikgruppe, 50968, Cologne, Germany.ORCID 0000-0002-9964-3465
Sonia LippkeJacobs University Bremen gGmbH, Campus Ring 1, 28759, Bremen, Germany. s.lippke@jacobs-university.de.ORCID 0000-0002-8272-0399
Constructor University · DEBecker Technologies (Germany) · DE

Funding

Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit Gesamt-2490-PC-2021-V7- D56613/2021
6 · The paper itself

Abstract

backgroundBecause the clinical patterns and symptoms that persist after a COVID-19 infection are diverse, a diagnosis of post-acute COVID-19 syndrome (PACS) is difficult to implement. The current research project therefore aims to evaluate the feasibility and the practicability of a comprehensive, interdisciplinary, and cross-sectoral treatment program consisting of a low-threshold online screening and holistic assessment for PACS. Furthermore, it aims to evaluate digital interventions and the use of so-called personal guides that may help to facilitate the recovery of PACS.

methodsThis German study consists of a low-threshold online screening for PACS where positively screened participants will be supported throughout by personal pilots. The personal pilots are aimed at empowering patients and helping them to navigate through the study and different treatment options. Patients will then be randomly assigned either to an intervention group (IG) or an active control group (ACG). The IG will receive a comprehensive assessment of physiological and psychological functioning to inform future treatment. The ACG does not receive the assessment but both groups will receive a treatment consisting of an individual digital treatment program (digital intervention platform and an intervention via a chatbot). This digital intervention is based on the needs identified during the assessment for participants in the IG. Compared to that, the ACG will receive a more common digital treatment program aiming to reduce PACS symptoms. Importantly, a third comparison group (CompG) will be recruited that does not receive any treatment. A propensity score matching will take place, ensuring comparability between the participants. Primary endpoints of the study are symptom reduction and return to work. Secondary outcomes comprise, for example, social participation and activities in daily life. Furthermore, the feasibility and applicability of the online screening tool, the holistic assessment, digital trainings, and personal pilots will be evaluated. DISCUSSION: This is one of the first large-scale studies to improve the diagnosis and the care of patients with PACS by means of empowerment. It is to be evaluated whether the methods utilized can be used for the German and international population. Trial registration ClinicalTrials.gov Identifier: NCT05238415; date of registration: February 14, 2022.

Indexed as

COVID-19HumansMass ScreeningPost-Acute COVID-19 SyndromeRandomized Controlled Trials as TopicSARS-CoV-2Treatment OutcomeCross-sectoral careDigital therapy offersInterdisciplinary diagnosticLong-COVIDLow-threshold screeningMedical rehabilitationPost-acute COVID-19 syndromePost-COVIDSymptom assessment

Identifiers

PMID35971066
PMCPMC9377288
OpenAlexW4291900872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.